Ep Biocomposites Ltd vs Genomic Valley Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 20, 2026

Key Highlights

The Latest Trading Price of EP Biocomposites Ltd is ₹ 102.7 as of 20 Mar 15:30 . The P/E Ratio of EP Biocomposites Ltd changed from 58.8 on March 2023 to 20.1 on March 2025 . This represents a CAGR of -30.08% over 3 yearsThe P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 years The Market Cap of EP Biocomposites Ltd changed from ₹ 33.88 crore on March 2023 to ₹ 20.75 crore on March 2025 . This represents a CAGR of -15.08% over 3 yearsThe Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 years The revenue of EP Biocomposites Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The ebitda of EP Biocomposites Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The net profit of EP Biocomposites Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The Dividend Payout of EP Biocomposites Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About EP Biocomposites Ltd

EP Biocomposites Limited was incorporated as Public Limited Company on January 17, 2020 with the Registrar of Companies, Goa.
Further, pursuant to Business Takeover Agreement dated August 31, 2021, the Company took over the running business of M/s.
OM Ventures, a proprietorship concern through one of its Promoter Leena Kamat.
In September 2022, Company made an Initial Public Offer of 5,04,000 Equity Shares of Rs 10 each by raising funds aggregating to Rs. 6.35 Crore. The Company is involved in manufacturing and supplying of a vast portfolio of products and services, which includes Fibre Glass doors and allied products, Bio Digester Toilets with DRDO technology and actively contributing to wastewater recycling through its solution in Sewage Treatment Plants (STP)and Effluent Treatment Plants (ETP).

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

FAQs for the comparison of EP Biocomposites Ltd and Genomic Valley Biotech Ltd

Which company has a larger market capitalization, EP Biocomposites Ltd or Genomic Valley Biotech Ltd?

Market cap of EP Biocomposites Ltd is 16 Cr while Market cap of Genomic Valley Biotech Ltd is 8 Cr

What are the key factors driving the stock performance of EP Biocomposites Ltd and Genomic Valley Biotech Ltd?

The stock performance of EP Biocomposites Ltd and Genomic Valley Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for EP Biocomposites Ltd and Genomic Valley Biotech Ltd?

As of March 20, 2026, the EP Biocomposites Ltd stock price is INR ₹98.0. On the other hand, Genomic Valley Biotech Ltd stock price is INR ₹28.43.

How do dividend payouts of EP Biocomposites Ltd and Genomic Valley Biotech Ltd compare?

To compare the dividend payouts of EP Biocomposites Ltd and Genomic Valley Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.